HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
